Symptomatische BPH: Wie effektiv ist die 5α-Reduktasehemmer-Monotherapie?
- PMID: 30522152
- DOI: 10.1055/s-0044-100026
Symptomatische BPH: Wie effektiv ist die 5α-Reduktasehemmer-Monotherapie?
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Comment on
-
Effects of Withdrawing α1-Blocker from Combination Therapy with α1-Blocker and 5α-Reductase Inhibitor in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: A Prospective and Comparative Trial Using Urodynamics.J Urol. 2017 Oct;198(4):905-912. doi: 10.1016/j.juro.2017.05.031. Epub 2017 May 10. J Urol. 2017. PMID: 28499730 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
